Amrutanjan Health Care Limited

Equities

AMRUTANJAN

INE098F01031

Pharmaceuticals

Market Closed - Bombay S.E. 03:51:31 14/05/2024 pm IST 5-day change 1st Jan Change
749.9 INR +1.97% Intraday chart for Amrutanjan Health Care Limited +0.34% +25.06%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Amrutanjan Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Amrutanjan Health Care Limited Declares Second Interim Dividend for the Financial Year 2023-24 CI
Amrutanjan Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Amrutanjan Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Amrutanjan Health Care Limited Declares First Interim Dividend for the Financial Year 2023-2024 CI
Amrutanjan Health Care Limited Declares Final Dividend for the Year Ended March 31, 2023 CI
Tranche Update on Amrutanjan Health Care Limited's Equity Buyback Plan announced on June 30, 2023. CI
Amrutanjan Health Care Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Tranche Update on Amrutanjan Health Care Limited's Equity Buyback Plan announced on June 30, 2023. CI
Amrutanjan Health Care Limited's Equity Buyback announced on June 30, 2023, has closed with 320,000 shares, representing 1.09% for INR 288 million. CI
Amrutanjan Health Care Gets Board's Nod to Buy Back Up to INR288 Million Worth of Shares; Shares Surge 12% MT
Amrutanjan Health Care Limited Announces Board Changes CI
Amrutanjan Health Care Limited announces an Equity Buyback for 320,000 shares, representing 1.09% for INR 288 million. CI
Amrutanjan Health Care Limited authorizes a Buyback Plan. CI
Amrutanjan Health Care Limited’s Board intends to launch an Equity Buyback on June 30, 2023. CI
Amrutanjan Health Care Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Amrutanjan Health Care Limited Recommends Final Dividend for the Financial Year 2022-2023 CI
Amrutanjan Health Care Limited Announces Demise of Pasumarthi Sathyanarayana Murthi, Non-Executive Non Independent Director CI
India's Amrutanjan Health Care sinks on whistleblower allegations RE
Amrutanjan Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Amrutanjan Health Care Limited Declares Interim Dividend for the Financial Year 2022-23 CI
INDIA STOCKS-Indian shares may open higher, tracking Asia, lower oil prices RE
Amrutanjan Health Care Limited Declares First Interim Dividend for the Financial Year 2022-23 CI
Amrutanjan Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
India's Amrutanjan Health Care Q2 profit slides as pandemic demand wanes RE
Chart Amrutanjan Health Care Limited
More charts
Amrutanjan Health Care Limited is an India-based company, which is engaged in the business of manufacturing, supplying and sale of products in pain management, congestion management, beverages, and hygiene. Its segments include OTC Products, Beverages, and Others. The OTC Products segment is engaged in manufacturing products for pain management, congestion management and hygiene. The Beverages segment is engaged in manufacturing fruit juices and oral hydration drinks. The Others segment includes the pain management center. The Company’s pain management products include Pain Balm Extra Power, Strong Pain Balm, New Maha Strong Pain Balm, Roll on and Advanced Back Pain + Roll-On, among others. Its congestion management products include Relief Cold Rub, Relief Nasal Inhaler, Relief Cough Syrup and Relief Swas Mint. Its women's hygiene products include Comfy Snug Fit, Comfy Snug Fit XL and Comfy Snug Fit ULTRA XL. The Company’s beverages include Fruitnik and Fruitnik Electro+.
More about the company
  1. Stock Market
  2. Equities
  3. AMRUTANJAN Stock
  4. News Amrutanjan Health Care Limited
  5. Amrutanjan Health Care Gets Board's Nod to Buy Back Up to INR288 Million Worth of Shares; Shares Surge 12%
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW